“…2 In a recent publication in Respirology, an expert Australasian (TSANZ) group provides an overview of the best management of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) based primarily on evidence and guideline recommendations. 3 In most regards, this was an excellent document, a highly informative management blueprint that meets the needs of many patients. It should be stressed that this position statement is not a guideline, but adapts the guideline ethos to routine practice.…”